DESs (drug-eluting stents) come under NICE (UK National Institute for Clinical Excellence) appraisal in UK
This article was originally published in Clinica
Executive Summary
The UK's National Institute for Clinical Excellence (NICE) has launched an appraisal consultation on the use of stents to treat coronary artery stenosis and the potential for using drug-eluting stents (DESs) to counter restenosis, or reclogging of the vessel.